⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekstri félagsins þann 13. nóvember nk.
globenewswire.com
ALVO
Alvotech Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm's Investigation
accessnewswire.com
ALVO
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
globenewswire.com
ALVO
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
globenewswire.com
ALVO
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
globenewswire.com
ALVO
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
globenewswire.com
ALVO